The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies

References

• Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975;55:871–876.
   PubMed Web of Science ®Google Scholar
• Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990;335:1572–1573.
   PubMed Web of Science ®Google Scholar
• Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988;319:1557–1562.
   PubMed Web of Science ®Google Scholar
• Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991;324:1852–1857.
   PubMed Web of Science ®Google Scholar
• Mumtaz K, Azam Z, Hamid S, Abid S, Memon S, Ali Shah H, et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009;3:563–570.
   PubMed Web of Science ®Google Scholar
• Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-Vergani G, Dhawan A. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl 2008;14:25–30.
   PubMed Web of Science ®Google Scholar
• Ben-Ari Z, Vaknin H, Tur-Kaspa R. N-acetylcysteine in acute hepatic failure (non-paracetamol-induced). Hepatogastroenterology 2000;47:786–789.
   PubMed Web of Science ®Google Scholar
• Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJ, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991;303:1026–1029.
   PubMed Web of Science ®Google Scholar
• Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364–1372.
   PubMed Web of Science ®Google Scholar
• Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int 2005;68:362–370.
   PubMed Web of Science ®Google Scholar
• Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008;74:1327–1334.
   PubMed Web of Science ®Google Scholar
• Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, et al. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila) 2014;52:856–867.
   PubMed Web of Science ®Google Scholar
• Borgstrom L, Kagedal B, Paulsen O. Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol 1986;31:217–222.
   PubMed Web of Science ®Google Scholar
• Holdiness MR. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 1991;20:123–134.
   PubMed Web of Science ®Google Scholar
• Soldini D, Zwahlen H, Gabutti L, Marzo A, Marone C. Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients. Eur J Clin Pharmacol 2005;60:859–864.
   PubMed Web of Science ®Google Scholar
• Sivilotti ML, Juurlink DN, Garland JS, Lenga I, Poley R, Hanly LN, et al. Antidote removal during haemodialysis for massive acetaminophen overdose. Clin Toxicol (Phila) 2013;51:855–863.
   PubMed Web of Science ®Google Scholar
• Nolin TD, Ouseph R, Himmelfarb J, McMenamin ME, Ward RA. Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease. Clin J Am Soc Nephrol 2010;5:1588–1594.
   PubMed Web of Science ®Google Scholar
• Jones AL, Jarvie DR, Simpson D, Hayes PC, Prescott LF. Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther 1997;11:787–791.
   PubMed Web of Science ®Google Scholar
• Polson J, Lee WM, American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179–1197.
   PubMed Web of Science ®Google Scholar
• Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977;72:573–583.
   PubMed Web of Science ®Google Scholar
• Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989;37:501–506.
   PubMed Web of Science ®Google Scholar
• Wu W, Goldstein G, Adams C, Matthews RH, Ercal N. Separation and quantification of N-acetyl-l-cysteine and N-acetyl-cysteine-amide by HPLC with fluorescence detection. Biomed Chromatogr 2006;20:415–422.
   PubMed Web of Science ®Google Scholar
• Schetz M. Drug dosing in continuous renal replacement therapy: general rules. Curr Opin Crit Care 2007;13:645–651.
   PubMed Web of Science ®Google Scholar
• Clark WR, Turk JE, Kraus MA, Gao D. Dose determinants in continuous renal replacement therapy. Artif Organs 2003;27:815–820.
   PubMed Web of Science ®Google Scholar
• Lee CS, Marbury TC. Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1984;9:42–66.
   PubMed Web of Science ®Google Scholar
• Gibson TP. Problems in designing hemodialysis drug studies. Pharmacotherapy 1985;5:23–29.
   PubMed Web of Science ®Google Scholar
• Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973;187:211–217.
   PubMed Web of Science ®Google Scholar
• Keller F, Offermann G, Scholle J. Kinetics of the redistribution phenomenon after extracorporeal elimination. Int J Artif Organs 1984;7:181–188.
   PubMed Web of Science ®Google Scholar